Impact of Curcumin and Pentoxiphylline on Chronic Kidney Disease Patients
Status:
COMPLETED
Trial end date:
2024-10-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to evaluate the impact of turmeric and pentoxiphylline on serum levels of protein-bound uremic toxin (p-cresyl sulfate), oxidative stress biomarker level (Malonaldehyde), inflammatory biomarker level (Highly sensitive C-reactive protein). In addition to the evaluation of its effect on metabolic profile and disease progression in chronic kidney disease patients.